Síndrome de Guillain-Barré como manifestación neurológica autoinmune asociado a COVID-19: Una revisión de la literatura

The coronavirus disease (COVID-19) caused by SARS-CoV-2 has been a challenge for health services around the world. The pandemic has spread widely, with more than 80 million confirmed cases and more than one million deaths globally. There have been many studies to understand all aspects of the diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Naranjo Arango, Yonatan Andrés, García Henao, Juan Pablo, Farfán Cortés, Abraham Yamit Amin Ariff, Álvarez Correa, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. 2022
Materias:
Artículo De Revisión
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914014/
http://dx.doi.org/10.1016/j.rcreu.2021.01.004
_version_ 1783656936683601920
author Naranjo Arango, Yonatan Andrés
García Henao, Juan Pablo
Farfán Cortés, Abraham Yamit Amin Ariff
Álvarez Correa, Daniela
author_facet Naranjo Arango, Yonatan Andrés
García Henao, Juan Pablo
Farfán Cortés, Abraham Yamit Amin Ariff
Álvarez Correa, Daniela
author_sort Naranjo Arango, Yonatan Andrés
collection PubMed
description The coronavirus disease (COVID-19) caused by SARS-CoV-2 has been a challenge for health services around the world. The pandemic has spread widely, with more than 80 million confirmed cases and more than one million deaths globally. There have been many studies to understand all aspects of the disease. Recently, several cases have been reported of patients with Guillain-Barré syndrome associated with COVID-19 as the main manifestation. As it may be one of the first autoimmune neurological diseases triggered by SARS-CoV-2, it is necessary to obtain more information to fully understand the immunopathogenic mechanisms involved in this association.
format Online
Article
Text
id pubmed-7914014
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-79140142021-03-01 Síndrome de Guillain-Barré como manifestación neurológica autoinmune asociado a COVID-19: Una revisión de la literatura Naranjo Arango, Yonatan Andrés García Henao, Juan Pablo Farfán Cortés, Abraham Yamit Amin Ariff Álvarez Correa, Daniela Revista Colombiana de Reumatología Artículo De Revisión The coronavirus disease (COVID-19) caused by SARS-CoV-2 has been a challenge for health services around the world. The pandemic has spread widely, with more than 80 million confirmed cases and more than one million deaths globally. There have been many studies to understand all aspects of the disease. Recently, several cases have been reported of patients with Guillain-Barré syndrome associated with COVID-19 as the main manifestation. As it may be one of the first autoimmune neurological diseases triggered by SARS-CoV-2, it is necessary to obtain more information to fully understand the immunopathogenic mechanisms involved in this association. Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. 2022-06 2021-02-27 /pmc/articles/PMC7914014/ http://dx.doi.org/10.1016/j.rcreu.2021.01.004 Text en © 2021 Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Artículo De Revisión
Naranjo Arango, Yonatan Andrés
García Henao, Juan Pablo
Farfán Cortés, Abraham Yamit Amin Ariff
Álvarez Correa, Daniela
Síndrome de Guillain-Barré como manifestación neurológica autoinmune asociado a COVID-19: Una revisión de la literatura
title Síndrome de Guillain-Barré como manifestación neurológica autoinmune asociado a COVID-19: Una revisión de la literatura
title_full Síndrome de Guillain-Barré como manifestación neurológica autoinmune asociado a COVID-19: Una revisión de la literatura
title_fullStr Síndrome de Guillain-Barré como manifestación neurológica autoinmune asociado a COVID-19: Una revisión de la literatura
title_full_unstemmed Síndrome de Guillain-Barré como manifestación neurológica autoinmune asociado a COVID-19: Una revisión de la literatura
title_short Síndrome de Guillain-Barré como manifestación neurológica autoinmune asociado a COVID-19: Una revisión de la literatura
title_sort síndrome de guillain-barré como manifestación neurológica autoinmune asociado a covid-19: una revisión de la literatura
topic Artículo De Revisión
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914014/
http://dx.doi.org/10.1016/j.rcreu.2021.01.004
work_keys_str_mv AT naranjoarangoyonatanandres sindromedeguillainbarrecomomanifestacionneurologicaautoinmuneasociadoacovid19unarevisiondelaliteratura
AT garciahenaojuanpablo sindromedeguillainbarrecomomanifestacionneurologicaautoinmuneasociadoacovid19unarevisiondelaliteratura
AT farfancortesabrahamyamitaminariff sindromedeguillainbarrecomomanifestacionneurologicaautoinmuneasociadoacovid19unarevisiondelaliteratura
AT alvarezcorreadaniela sindromedeguillainbarrecomomanifestacionneurologicaautoinmuneasociadoacovid19unarevisiondelaliteratura

Ejemplares similares